Australia markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0640-0.0010 (-1.54%)
At close: 04:10PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
10,343
11,249
10,495
8,353
5,694
Cost of revenue
1,367
1,546
1,709
1,602
1,678
Gross profit
8,976
9,703
8,786
6,751
4,016
Operating expenses
Research development
236
598
683
1,456
3,308
Selling general and administrative
20,050
19,964
20,226
22,972
20,965
Total operating expenses
32,704
32,696
30,323
29,824
29,573
Operating income or loss
-23,728
-22,993
-21,537
-23,073
-25,557
Total other income/expenses net
3,019
1,703
1,691
2,437
4,189
Income before tax
-19,396
-20,490
-19,828
-20,667
-21,329
Income tax expense
28
31
46
39
48
Income from continuing operations
-19,424
-20,521
-19,874
-20,706
-21,377
Net income
-19,424
-20,521
-19,874
-20,706
-21,377
Net income available to common shareholders
-19,424
-20,521
-19,874
-20,706
-21,377
Basic EPS
-0.01
-0.01
-0.01
-0.02
-0.04
Diluted EPS
-0.01
-0.01
-0.01
-0.02
-0.04
Basic average shares
1,800,349
1,800,349
1,678,954
1,202,320
595,167
Diluted average shares
1,800,349
1,800,349
1,678,954
1,202,320
595,167